Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Restifo
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Myc Target in Myeloid Cells-1, a Novel C-Myc Target, Recapitulates Multiple C-Myc Phenotypes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Feature-Based Analysis Identifies COL1A2 as a Regulator in Pancreatic Cancer
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
DLK1 as a Potential Target Against Cancer Stem/Progenitor Cells of Hepatocellular Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Reply to Mengxin Lu, Yi Zhang, Yu Xiao’s Letter to the Editor, Re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, Et Al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-Derived Cells. Eur Urol. In Press.
European Urology
Urology
Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma
International Journal of Oncology
Cancer Research
Oncology
Bioengineered miRNA-1291 Prodrug Therapy in Pancreatic Cancer Cells and Patient-Derived Xenograft Mouse Models
Cancer Letters
Cancer Research
Oncology
Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
